Fresh Food Farmacy: A Randomized Controlled Trial
Completed · Not applicable
Conditions studied: Type 2 Diabetes
In brief
This trial investigates the value created by the highly innovative Fresh Food Farmacy (FFF) program at Geisinger Health. The program provides food-insecure diabetics with healthy food for their entire household: at least two meals per day, five days a week. The program also provides education on how to prepare the food, and education on healthy living including diabetes self management. The research measures the effects of the FFF program on patient health and wellbeing.
Key facts
- Study ID
- NCT03718832
- Run by
- John B Bulger, DO
- People needed
- 500
- Starts
- 2019-04-22
- Expected to finish
- 2023-11-30
- Last updated by the study team
- 2025-06-12
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Type II Diabetes and an HbA1c ≥ 8.0 as determined by the most recent measurement in the Geisinger EMR within the prior 12 months
- Food insecure based on a two-question survey instrument
- Age > 17 \& Age <86
- Living within geographic reach of the program (Lewistown, PA and Scranton, PA)
You may not qualify if…
- Already enrolled in FFF in Shamokin
- Not English speaking (working on changing this as the program evolves)
- On hospice or palliative care
- Acute or chronic psychosis
- Resides in a facility which provides meals
- Active medical disorder that would preclude participation in the classes, weekly clinic visits, or result in a limited diet, including:
- Cancer; active treatment
- Steroid dependent asthma/ COPD/ emphysema
- Steroid dependent Colitis
- Chronic Kidney Disease with GFR< 30 mg/mmol
- Celiac disease
- Cirrhosis
- Steroid dependent arthritis
Where it is running
- Fresh Food Farmacy — Lewistown, Pennsylvania, United States
- Fresh Food Farmacy — Scranton, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.